Investors Relations
Investors Relations
Get started
Live demo
Pipeline
Pipeline
Publicly funded programs
Publicly funded programs
KMUi-Biomedizin-1: Entwicklung und präklinische Qualifizierung neuartiger Parodontitis-Therapeutika für die klinische Anwendung (ParoPaste) - Erforschung und präklinische Qualifizierung neuartiger Parodontitis-Therapeutika in Proof-of-Concept Modellen und regulatorische Vorbereitung für die klinische Anwendung
Read more
Alternative metal binding groups in drugs for the treatment of periodontitis - AMePA
Read more
Controlled release drug delivery systems of innovative and selective drug molecules for the treatment of bacterial infectious diseases of the periodontum – ParoStop
Read more
Profiling inhibitors of bacterial glutaminyl cyclases as drug prototypes of novel periodontal therapeutics - PInParo
Read more
Awards & Investments By
Awards
Investments By
Publications
Publications
2024
Preclinical Validation of MIN-T: A Novel Controlled-Released Formulation for the Adjunctive Local Application of Minocycline in Periodontitis
https://www.sciencedirect.com/science/
article/pii/S0378517319308397
https://www.mdpi.com/2079-6382/13/11/1012
2019
Extrudates of lipophilic tetracycline complexes: A new option for periodontitis therapy
https://www.sciencedirect.com/science/
article/pii/S0378517319308397
https://www.sciencedirect.com/science/article/pii/S0378517319308397
2020
Controlled release minocycline-lipid-complex extrudates for the therapy of periodontitis with enhanced flexibility
https://www.sciencedirect.com/science/article/pii/S0378517320305627
https://www.sciencedirect.com/science/
article/pii/S0378517320305627
2020
In Vitro Evaluation of Antimicrobial Activity of Minocycline Formulations for Topical Application in Periodontal Therapy
https://www.mdpi.com/1999-4923/12/4/352
2021
Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis
https://www.sciencedirect.com/science/article/pii/S0021925821000302
https://www.sciencedirect.com/science/
article/pii/S0021925821000302
2021
Tetrahydroimidazo[4,5-c]pyridine-Based Inhibitors of Porphyromonas gingivalis Glutaminyl Cyclase
https://www.mdpi.com/1372046